Veritas Pharma Inc. Management Discussion and Analysis Amendment and Restatement
VANCOUVER, BC / ACCESSWIRE / November 9, 2016 / Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), ("Veritas" or the "Company"), as a result of a review by the British Columbia Securities Commission, is issuing the following press release to clarify our disclosure. We have amended and restated our Management Discussion and Analysis ("MD&A") to more fully disclose the effect of the advances by the Company to CTL. The MD&A has...
Read more








